XGN · Exagen Inc
United States · RS rating 94 · As of 2026-10-14
| Price | 8.42 USD |
|---|---|
| 1-day change | -0.7% |
| RS rating (overall / 1M / 3M / 12M) | 94 / 95 / 97 / 24 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 45 / 50 / 40 |
| Industry group (rank) | Medical-Research Eqp/Svc (31) |
| EPS growth Q/Q | +35.5% |
| Sales growth Q/Q | -3.5% |
| Distance from 52-week high | +29.6% |
| Market cap (USD) | $64.5M |